Bioactivity:

Liarozole HCl is a benzimidazole derivative with antineoplastic activity. As a retinoic acid metabolism blocking agent, liarozole inhibits CYP450-dependent all-trans-retinoic acid (ATRA)-4-hydroxylase, leading to an increase in endogenous ATRA production,

CAS nr:

145858-50-0

Purity:

98%

Molecular Weight:

345,22

SMILES:

ClC1=CC(C(C2=CC=C3C(N=CN3)=C2)N4C=CN=C4)=CC=C1.[H]Cl

Formula:

C17H14Cl2N4

Pathway:

Target: